Correlation Between MAIA Biotechnology and Lumos Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MAIA Biotechnology and Lumos Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MAIA Biotechnology and Lumos Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MAIA Biotechnology and Lumos Pharma, you can compare the effects of market volatilities on MAIA Biotechnology and Lumos Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MAIA Biotechnology with a short position of Lumos Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of MAIA Biotechnology and Lumos Pharma.

Diversification Opportunities for MAIA Biotechnology and Lumos Pharma

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between MAIA and Lumos is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding MAIA Biotechnology and Lumos Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lumos Pharma and MAIA Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MAIA Biotechnology are associated (or correlated) with Lumos Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lumos Pharma has no effect on the direction of MAIA Biotechnology i.e., MAIA Biotechnology and Lumos Pharma go up and down completely randomly.

Pair Corralation between MAIA Biotechnology and Lumos Pharma

Given the investment horizon of 90 days MAIA Biotechnology is expected to under-perform the Lumos Pharma. In addition to that, MAIA Biotechnology is 5.7 times more volatile than Lumos Pharma. It trades about -0.13 of its total potential returns per unit of risk. Lumos Pharma is currently generating about -0.02 per unit of volatility. If you would invest  436.00  in Lumos Pharma on August 24, 2024 and sell it today you would lose (3.00) from holding Lumos Pharma or give up 0.69% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

MAIA Biotechnology  vs.  Lumos Pharma

 Performance 
       Timeline  
MAIA Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MAIA Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Lumos Pharma 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Lumos Pharma are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak primary indicators, Lumos Pharma displayed solid returns over the last few months and may actually be approaching a breakup point.

MAIA Biotechnology and Lumos Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MAIA Biotechnology and Lumos Pharma

The main advantage of trading using opposite MAIA Biotechnology and Lumos Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MAIA Biotechnology position performs unexpectedly, Lumos Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lumos Pharma will offset losses from the drop in Lumos Pharma's long position.
The idea behind MAIA Biotechnology and Lumos Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing